⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HUMA News
Humacyte, Inc. Common Stock
Humacyte Announces FDA Acceptance of IND for First-In-Human Clinical Study of CTEV for Coronary Artery Bypass Grafting
globenewswire.com
HUMA
Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access
globenewswire.com
HUMA
Humacyte's Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual Meeting
globenewswire.com
HUMA
Form 8-K
sec.gov
HUMA
HUMAW
Humacyte, Inc. Announces Pricing of Public Offering of Common Stock
globenewswire.com
HUMA
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
globenewswire.com
HUMA
Form 8-K
sec.gov
HUMAW
HUMA
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
globenewswire.com
HUMA
Humacyte ATEV Met Superiority Primary Endpoint Compared to Standard of Care AV Fistula in Interim Analysis of V012 Phase 3 Study in Female Dialysis Access Patients
globenewswire.com
HUMA
Form 8-K
sec.gov
HUMAW
HUMA